We observed that a large amount of the ITF2 protein was regulated through the ubiquitin-proteasome degradation system by treating four colon cancer lines with the proteasome inhibitor MG132 (Fig. 2G). This evidence concerns the gene TCF4 and malignant colon neoplasm.